COMPANY

Company Identity

LEADING GLOBAL R&D Innovator

CURACLE Co., Ltd. presents a healthy and happy life by developing innovative global
new drugs for intractable vascular diseases.

Embarking on a New Challenge, Miracle Cure, Leading Global Market

  • Present

    Unmet Medical Needs

    • Diabetic Macular Edema(DME)
    • Wet Macular Degeneration
    • Inflammatory Bowel Disease(Ulcerative Colitis, Crohn’s Disease)
    • Cancer
    • Diabetic Nephropathy
    • Ischemic Vascular Diseases
    • Stroke
    • Kidney Failure
    • Dementia, etc.

    Key Development

    Age-Related Vascular Diseases

    Intractable Metabolic Diseases

    Targeted Therapy / Immunotherapy for Cancer

    Future

    Creative Scientific Discovery

    Innovative Molecules

    New Clinical Concept

    • Vascular Normalization
    • Inhibition of Abnormal Angiogenesis
    • Suppression of Inflammation

    Novel Therapeutics
    Leading rapidly growing present and future market

Global enterprise growth by developing unparalleled platform technology and creating innovative new drugs

Strengthening market leadership through the continued success of pipelines and global partnerships

  • Growth stage
    (-2020)

    • Portfolio consisting of drug candidates and early phase clinical trials
    • Completed Phase 2a clinical trial of CU01 & CU03
    • Entered Phase 1 clinical trial of CU06
    • Completed Series B financing
    • Build relationship with domestic and foreign partners
    • Completed technology assessment for special listings

  • Take-off Stage
    (2021-2025)

    • Add new innovative pipeline
    • Initial Public Offering (IPO)
    • Portfolio consisting of pre-clinical and late phase clinical trials
    • Out-licensing and co-development with domestic and international pharmaceutical companies
    • Creation of milestone profits
    • Laboratory integration
    • Addition of new innovative pipelines

  • Achieving VISION
    (2026-)

    • Establish unrivaled and innovative drug platform
    • Launch internally developed drugs worldwide
    • Global R&D innovator leader focused on unmet medical needs